A Cleveland Clinic gastroenterologist breaks new ground with the use of noninvasive exhaled breath testing as a screening tool in pediatric medicine.
After demonstrating that breath analysis can detect pediatric nonalcoholic fatty liver disease, Cleveland Clinic Children’s is assessing the technique’s utility in diagnosing other pediatric gastrointestinal conditions.
No one needs to tell Dr. Naim Alkhouri that invasive tests for nonalcoholic fatty liver disease are ill-suited to kids. His quest to find a noninvasive alternative has him exploring a host of promising options.
This year’s American College of Gastroenterology annual conference will focus on key trends important to your GI practice. Find out what the hot topics are from physicians at Cleveland Clinic
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Three-quarters of a sample of obese kids had at least one obesity-related comorbidity, and nearly half had two or more comorbidities. Check out these and other insights from the clinic’s early research initiatives.
Isoprene in exhaled breath is highly accurate in detecting advanced liver fibrosis and could avoid the need for biopsy in up to 75 percent of patients.
A post-liver transplant patient with HIV and recurrent HCV was successfully treated by switching his protease inhibitor until the HCV resolved, then restoring his HAART regimen.
A Children’s Metabolic Liver Disease Clinic is looking for ways to recognize these silent diseases early in their onset. Care is comprehensive for young patients with a multidisciplinary approach, which often includes a pediatric hepatologist along with a dietitian and an exercise physiologist. Recent research has focused on finding potential biomarkers for nonalcoholic fatty liver disease (NAFLD).
Exhaled breath analysis shows promise for noninvasive diagnosis